Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

OPTN | OptiNose Inc

Healthcare | Drug Manufacturers - Specialty & Generic | USA | NASD

Index	RUT	P/E	-	EPS (ttm)	-0.48	Insider Own	26.73%	Shs Outstand	111.49M	Perf Week	-2.38%
Market Cap	138.03M	Forward P/E	-	EPS next Y	-0.25	Insider Trans	-0.07%	Shs Float	82.23M	Perf Month	-2.38%
Income	-46.38M	PEG	-	EPS next Q	-0.09	Inst Own	60.10%	Short Float / Ratio	5.53% / 11.94	Perf Quarter	0.00%
Sales	72.23M	P/S	1.91	EPS this Y	62.27%	Inst Trans	-0.28%	Short Interest	4.55M	Perf Half Y	-39.11%
Book/sh	-0.62	P/B	-	EPS next Y	22.98%	ROA	-40.52%	Target Price	3.00	Perf Year	-65.45%
Cash/sh	0.64	P/C	1.94	EPS next 5Y	-	ROE	-	52W Range	0.90 - 3.74	Perf YTD	-33.51%
Dividend	-	P/FCF	-	EPS past 5Y	10.53%	ROI	-	52W High	-67.10%	Beta	-0.16
Dividend %	-	Quick Ratio	0.58	Sales past 5Y	97.23%	Gross Margin	87.01%	52W Low	36.67%	ATR	0.08
Employees	141	Current Ratio	0.63	Sales Q/Q	-5.48%	Oper. Margin	-52.19%	RSI (14)	47.17	Volatility	6.81% 6.02%
Optionable	No	Debt/Eq	-	EPS Q/Q	-	Profit Margin	-64.20%	Rel Volume	0.60	Prev Close	1.24
Shortable	Yes	LT Debt/Eq	-	Earnings	Aug 10 BMO	Payout	-	Avg Volume	380.59K	Price	1.23
Recom	1.00	SMA20	-2.15%	SMA50	-0.36%	SMA200	-19.78%	Volume	228,117	Change	-0.81%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-21-23	Initiated	Lake Street	Buy	$3
Oct-21-22	Resumed	Jefferies	Buy	$5
Apr-07-21	Resumed	RBC Capital Mkts	Outperform	$17
Dec-18-19	Initiated	Cowen	Outperform	$25
Aug-08-18	Initiated	Cantor Fitzgerald	Overweight

Sep-22-23 09:01AM	Optinose to Present at the 2023 Cantor Global Healthcare Conference (GlobeNewswire)
Aug-12-23 09:58AM	OptiNose, Inc. (NASDAQ:OPTN) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-10-23 08:54PM	Q2 2023 OptiNose Inc Earnings Call (Thomson Reuters StreetEvents) +6.90%
08:25AM	OptiNose (OPTN) Q2 Earnings and Revenues Top Estimates (Zacks)
07:27AM	OptiNose: Q2 Earnings Snapshot (AP Finance)
07:00AM	Loading…
07:00AM	Optinose Reports Second Quarter 2023 Financial Results and Operational Updates (GlobeNewswire)
Aug-09-23 07:55PM	Profound Medical (PROF) Reports Q2 Loss, Misses Revenue Estimates (Zacks) -5.69%
Jul-27-23 07:00AM	Optinose Announces Preliminary Second Quarter 2023 XHANCE Net Revenue of $19.5 Million (GlobeNewswire)
Jul-07-23 08:28AM	When Will OptiNose, Inc. (NASDAQ:OPTN) Breakeven? (Simply Wall St.)
Jun-16-23 04:08PM	Optinose Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-10-23 08:16AM	OptiNose, Inc. (NASDAQ:OPTN) is definitely on the radar of institutional investors who own 39% of the company (Simply Wall St.)
Jun-02-23 01:00PM	Optinose to Present at the Jefferies Healthcare Conference (GlobeNewswire)
May-14-23 08:08AM	US$4.17: That's What Analysts Think OptiNose, Inc. (NASDAQ:OPTN) Is Worth After Its Latest Results (Simply Wall St.)
May-11-23 10:43PM	Q1 2023 OptiNose Inc Earnings Call (Thomson Reuters StreetEvents) +6.45%
08:55AM	OptiNose (OPTN) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:54AM	Loading…
07:54AM	OptiNose: Q1 Earnings Snapshot (AP Finance)
07:00AM	Optinose Reports First Quarter 2023 Financial Results and Operational Updates (GlobeNewswire)
May-04-23 07:00AM	Optinose Announces FDA Acceptance of Supplemental New Drug Application for XHANCE (GlobeNewswire) +11.43%
May-01-23 04:30PM	Optinose Announces Reporting Date for First Quarter 2023 Financial Results (GlobeNewswire)
Apr-18-23 12:43PM	OptiNose, Inc.'s (NASDAQ:OPTN) Business Is Trailing The Industry But Its Shares Aren't (Simply Wall St.)
08:00AM	Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-12-23 04:00PM	Optinose to Present at the Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-11-23 07:29AM	OptiNose, Inc. (NASDAQ:OPTN) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-09-23 06:24AM	We're Not Very Worried About OptiNose's (NASDAQ:OPTN) Cash Burn Rate (Simply Wall St.) -8.42%
Mar-07-23 11:22PM	Q4 2022 OptiNose Inc Earnings Call (Thomson Reuters StreetEvents)
08:35AM	OptiNose (OPTN) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:00AM	Optinose Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Operational Highlights (GlobeNewswire)
Mar-06-23 02:03AM	Silence Therapeutics PLC Sponsored ADR (SLN) Stock Jumps 9.3%: Will It Continue to Soar? (Zacks) +5.56%
Feb-28-23 04:30PM	Optinose Announces Reporting Date for Fourth Quarter 2022 Financial Results (GlobeNewswire)
Feb-21-23 02:29PM	Bucks County firm seeks to expand approval for flagship product (American City Business Journals)
07:00AM	Loading…
07:00AM	Optinose Submits Supplemental New Drug Application for XHANCE Label Expansion (GlobeNewswire)
Jan-31-23 12:03PM	Optinose CEO Peter Miller resigns after 13 years; successor named (American City Business Journals)
07:00AM	Optinose Announces CEO Transition and Business Update (GlobeNewswire)
Dec-27-22 09:27AM	OptiNose, Inc.'s (NASDAQ:OPTN) top owners are private equity firms with 37% stake, while33% is held by institutions (Simply Wall St.)
Dec-15-22 04:30PM	Optinose Appoints Paul Spence as Chief Commercial Officer (GlobeNewswire)
Dec-09-22 08:00AM	Optinose Announces Departure of Acting Chief Financial Officer (GlobeNewswire) -7.94%
Nov-30-22 07:00AM	Optinose Announces Corporate Updates and Presentation at the 34th Annual Piper Sandler Healthcare Conference (GlobeNewswire)
Nov-22-22 02:24PM	Bucks County health care company expects to raise $50M (American City Business Journals) +5.71%
Nov-21-22 08:30AM	Optinose Announces Pricing of Public Offering of Common Stock and Warrants (GlobeNewswire) -7.89%
06:12AM	Optinose Announces Proposed Public Offering of Common Stock and Warrants (GlobeNewswire)
Nov-16-22 05:24AM	Analysts Are More Bearish On OptiNose, Inc. (NASDAQ:OPTN) Than They Used To Be (Simply Wall St.)
Nov-12-22 07:54AM	OptiNose Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag (Simply Wall St.)
Nov-10-22 08:15AM	OptiNose (OPTN) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -15.08%
08:00AM	Edited Transcript of OPTN.OQ earnings conference call or presentation 10-Nov-22 1:00pm GMT (Thomson Reuters StreetEvents)
07:00AM	Optinose Reports Third Quarter 2022 Financial Results and Operational Updates (GlobeNewswire)
Nov-09-22 03:00PM	Optinose Announces ReOpen2 Presentation at the American College of Asthma, Allergy, and Immunology (ACAAI) 2022 Annual Scientific Meeting (GlobeNewswire) -6.34%
Nov-07-22 03:00PM	Optinose Announces Reporting Date for Third Quarter 2022 Financial Results (GlobeNewswire)
Oct-21-22 07:00AM	Optinose Announces Late Breaking Abstract Podium Presentation at IDWeek 2022 (GlobeNewswire)
Oct-16-22 08:24AM	Shareholders in OptiNose (NASDAQ:OPTN) are in the red if they invested five years ago (Simply Wall St.)
Sep-18-22 10:44AM	When Can We Expect A Profit From OptiNose, Inc. (NASDAQ:OPTN)? (Simply Wall St.)
Sep-06-22 12:00PM	Optinose Announces ReOpen1 Abstract Selected for Presentation at the American Rhinologic Society Annual Meeting (GlobeNewswire)
Aug-17-22 10:00AM	2 Stocks That Should Perform Well Even if Consumers Pull In Their Horns (TheStreet.com)
Aug-11-22 08:15AM	OptiNose (OPTN) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
07:00AM	Optinose Reports Second Quarter 2022 Financial Results and Operational Updates (GlobeNewswire)
Aug-08-22 04:20PM	Optinose Announces Reporting Date for Second Quarter 2022 Financial Results (GlobeNewswire)
Jul-14-22 08:45AM	10 Best Penny Stocks to Buy in July (Insider Monkey)
Jul-13-22 10:58AM	Pooled Data Show Optinose's XHANCE Cut Sinusitis Flares By 66% (Benzinga)
07:44AM	Organogenesis (ORGO) Stock Jumps 5.3%: Will It Continue to Soar? (Zacks)
07:00AM	Optinose Announces that XHANCE Significantly Reduced Incidence of Exacerbations for Patients with Chronic Sinusitis in Landmark ReOpen Program (GlobeNewswire)
Jul-08-22 08:23AM	Optinose Shared Additional Encouraging Data From Late-Stage Chronic Sinusitis Studies (Benzinga)
07:00AM	Optinose Announces Additional Positive Results from ReOpen2 and Initial Results from Pooled Analyses of Both Trials in the ReOpen Program (GlobeNewswire)
Jun-13-22 11:10AM	Optinose Stock Moves Higher On Positive Second Chronic Sinusitis Phase 3 Trial (Benzinga) +41.08%
07:00AM	Optinose Announces Positive Top-line Results of ReOpen2, its second Phase 3 Clinical Trial of XHANCE for Treatment of Chronic Sinusitis (GlobeNewswire)
Jun-03-22 07:00AM	Optinose Announces Departure of Chief Financial Officer (GlobeNewswire)
May-12-22 08:15AM	OptiNose (OPTN) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -5.38%
07:00AM	Optinose Reports First Quarter 2022 Financial Results and Operational Updates (GlobeNewswire)
May-10-22 07:15AM	Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-09-22 05:35PM	Revolution Medicines, Inc. (RVMD) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -9.26%
May-05-22 05:00PM	Optinose Announces Reporting Date for First Quarter 2022 Financial Results (GlobeNewswire)
Apr-26-22 08:00AM	Optinose Announces Appointment of R. John Fletcher to the Board (GlobeNewswire)
Apr-08-22 08:30AM	Optinose to Present at the Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-08-22 08:15AM	OptiNose (OPTN) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -6.55%
07:00AM	Optinose Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Operational Highlights (GlobeNewswire)
Mar-07-22 07:00AM	Optinose Reports Positive Top-line Results in ReOpen1, a Landmark Phase 3 Trial for XHANCE in Chronic Sinusitis (GlobeNewswire)
Mar-04-22 02:00PM	Optinose Announces Reporting Date for Fourth Quarter 2021 Financial Results (GlobeNewswire)
Feb-23-22 03:00PM	OptiNose (OPTN) May Report Negative Earnings: Know the Trend Ahead of Q4 Release (Zacks)
Jan-24-22 09:40AM	Is NuCana PLC Sponsored ADR (NCNA) Outperforming Other Medical Stocks This Year? (Zacks)
Dec-28-21 09:38AM	Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ... (GuruFocus.com)
Dec-21-21 09:38AM	Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ... (GuruFocus.com)
Dec-17-21 06:52AM	Rising P/E: An Overlooked Trick to Land on 5 Winning Stocks (Zacks)
Dec-16-21 09:38AM	Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ... (GuruFocus.com)
Dec-13-21 07:54AM	Optinose Announces Appointment of Two New Members to Board of Directors (GlobeNewswire)
Dec-08-21 09:38AM	Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ... (GuruFocus.com)
Nov-23-21 07:00AM	Optinose to Present at the Piper Sandler Virtual Healthcare Conference (GlobeNewswire) +7.10%
05:41AM	OptiNose (OPTN) Sees Hammer Chart Pattern: Time to Buy? (Zacks)
Nov-22-21 10:00AM	After Plunging 44.2% in 4 Weeks, Here's Why the Trend Might Reverse for OptiNose (OPTN) (Zacks)
Nov-18-21 04:30PM	Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -10.25%
02:00PM	Optinose Announces Closing of $46.0 Million Public Offering of Common Stock (GlobeNewswire)
Nov-17-21 12:36PM	Optinose seeking $40M from stock sale to advance drug-device combo product (American City Business Journals) +13.52%
Nov-16-21 02:35PM	Mid-Afternoon Market Update: Dow Jumps 150 Points; Talkspace Shares Slide (Benzinga) -33.47%
12:07PM	Mid-Day Market Update: Crude Oil Down 1%; Kezar Life Sciences Shares Surge (Benzinga)
08:02AM	Optinose Announces Pricing of Public Offering of Common Stock (GlobeNewswire)
Nov-15-21 07:05PM	OptiNose (OPTN) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
05:40PM	Optinose Announces Proposed Public Offering of Common Stock (GlobeNewswire)
04:26PM	Optinose Reports Third Quarter 2021 Financial Results and Recent Operational Highlights (GlobeNewswire)
Nov-10-21 05:50PM	Optinose Announces Reporting Date for Third Quarter 2021 Financial Results (GlobeNewswire)
Oct-28-21 03:05PM	Will OptiNose (OPTN) Report Negative Q3 Earnings? What You Should Know (Zacks)
06:59AM	Optinose Completes Patient Recruitment in Second Pivotal Trial for XHANCE in Chronic Sinusitis (GlobeNewswire)
Sep-22-21 04:15PM	Optinose to Present at the Cantor Virtual Global Healthcare Conference (GlobeNewswire)
Aug-25-21 05:00PM	Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)

OptiNose, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in October 2000 and is headquartered in Yardley, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Mahmoud Ramy A	Chief Executive Officer	Sep 18	Sale	1.37	11,083	15,184	514,729	Sep 19 07:05 PM
Marino Michael F III	Chief Legal Officer & Corp Sec	Sep 18	Sale	1.37	4,991	6,838	334,699	Sep 19 07:04 PM
Mahmoud Ramy A	Chief Executive Officer	Jun 16	Sale	1.15	3,543	4,074	519,699	Jun 20 01:03 PM
Marino Michael F III	Chief Legal Officer & Corp Sec	Jun 16	Sale	1.15	1,516	1,743	335,873	Jun 20 01:04 PM
Mahmoud Ramy A	Chief Executive Officer	Mar 16	Sale	1.79	11,040	19,762	517,128	Mar 20 04:00 PM
Marino Michael F III	Chief Legal Officer & Corp Sec	Mar 16	Sale	1.79	4,972	8,900	333,573	Mar 20 04:02 PM
Miller Peter K	Chief Executive Officer	Jan 13	Sale	1.77	29,664	52,505	853,384	Jan 17 09:48 AM
Marino Michael F III	Chief Legal Officer & Corp Sec	Jan 13	Sale	1.77	5,241	9,277	180,353	Jan 17 09:51 AM
Miller Peter K	Chief Executive Officer	Dec 16	Sale	1.69	15,253	25,778	883,048	Dec 19 01:46 PM
Clavelli Victor M	Chief Commercial Officer	Dec 16	Sale	1.69	3,208	5,422	199,955	Dec 19 01:48 PM
Marino Michael F III	Chief Legal Officer & Corp Sec	Dec 16	Sale	1.69	2,751	4,649	185,594	Dec 19 01:50 PM
Janis Michele	Acting Chief Financial Officer	Dec 16	Sale	1.69	1,015	1,715	48,927	Dec 19 01:49 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

OPTN | OptiNose Inc

Upgrade your FINVIZ experience